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Introduction
Paraganglia are neuroendocrine organs that originate 
from the neural crest cells that are closely associated 
with the autonomic nervous system.1 Paragangliomas 
and phaeochromocytomas are tumours that arise 
from these organs. Paragangliomas are extra-adrenal 
tumours that can be divided into sympathetic and 
parasympathetic, and are further categorised by 
site.1 The term “phaeochromocytoma” is reserved for 
intra-adrenal tumours. The most common location of 
these extra-adrenal paragangliomas is the inferior 
para-aortic region (also known as the organ of 
Zuckerkandl).1 Other extra-adrenal sites that have been 
described include the bladder, pelvis, prostate, ovaries 
and thorax.1 According to McNicol, the estimated 
incidence of paragangliomas is 1:300 000. At least 30% 
of paragangliomas have a hereditary occurrence. 
Approximately 10% are syndromic.1 We describe a 
case of extra-adrenal pelvic paraganglioma that 
caused hypertension in pregnancy. 
Case report
A 31-year-old black woman, pregnant for the fifth time, 
presented at 31 weeks’ gestation with pre-existent 
hypertension, superimposed pre-eclampsia and 
acute heart failure. She had a previous history of three 
stillbirths and one miscarriage due to uncontrolled 
hypertension. After her fourth pregnancy, she remained 
on antihypertensive medication. On admission, her 
blood pressure was 266/195 mmHg and she was treated 
with intravenous labetalol. A Caesarean section was 
performed and a 1.44 kg baby boy was delivered. 
It was very difficult to control the blood pressure post-
partum and the patient was treated with hydrochlo-
rothiazide, atenolol, enalapril and amlodipine. At this 
stage, baseline investigation results included normal 
urea and creatinine, a normal renal sonar and a cre-
atinine clearance of 81 ml/minute, with no proteinuria. 
Echocardiography was normal, with a left ventricle 
ejection fraction of 52%.
Five months postpartum, the patient was referred 
to the division of endocrinology with a possible 
phaeochromocytoma. The patient provided a history 
of experiencing feelings of impending doom when 
in the supine position just after micturition, as well as 
headaches, palpitations and sweating. These spells 
started during her fifth pregnancy at three months’ 
gestation and disappeared approximately two months 
postpartum. A clinical examination did not reveal any 
target organ damage and her blood pressure was 
122/70 mmHg on medication.
Twenty-four-hour urine results were as follows: met-
adrenaline 1 539 nmol/24 hour (n: 264-1 729), met-
noradrenaline 227 641 nmol/24 hour (n: 480-2 424), 
metadrenaline/creatinine ratio of 170 nmol/mmol 
(n: 15-89) and metnoradrenaline/creatinine ratio 
25 085 nmol/mmol (n: 28-158).
A computerised tomography scan showed a presacral 
mass measuring 6.6 x 6.6 cm (units were standardised 
throughout the case), with significant post-contrast 
enhancement. The mass extended inferior between 
the rectum and uterus. Possible sacral infiltration was 
noted superiorly. The mass was in keeping with a pelvic 
paraganglioma or possible ovarian mass. The adrenals 
appeared to be normal. 
One month later, magnetic resonance imaging 
revealed a large tumour in the pelvis, just anterior to 
the sacrum. It measured 6.9 x 9.1 x 7.2 cm and was 
situated slightly left of the midline. It seemed to infiltrate 
the sacrum, with no extension into the spinal canal. The 
lesion was nonhomogenous on T2-weighted imaging 
and isointense to muscle on T1-weighted imaging, with 
a prominent vascular supply (see Figure 1).
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An I-123 metaiodobenzylguanidine (MIBG) scan 
showed a solitary presacral mass lesion with high MIBG 
uptake. This picture was compatible with a functional 
paraganglioma. No metastases were identified (see 
Figure 2).
Surgical excision of the tumour was planned. The 
patient was adequately α-blocked with doxazosin 
preoperatively. In addition, she was given paracetamol 
and hydroxyzine as premedication.
Intraoperatively, the paraganglioma was located in 
the pelvis, inferior to the bifurcation of the aorta. It was 
not attached to any other organs. The patient had 
massive hypertensive responses during tumour manipu-
lation and systolic blood pressures of up to 250 mmHg. 
This response was difficult to control with a nitroglycer-
ine infusion, remifentanil infusion, magnesium sulphate 
and sevoflurane in oxygen and air.
After the arterial and venous blood supply 
of the tumour was tied off, the patient had 
a severe hypotensive episode. The mean 
arterial pressure fell below 60 mmHg for a 
period of nine minutes. This was accompa-
nied by substantial blood loss during remov-
al of the tumour. The hypotension was man-
aged with aggressive fluid resuscitation with 
packed cells. Intraoperatively, the patient 
received eight units of packed cells, eight 
units of cryoprecipitate, four units of fresh 
frozen plasma and one unit of platelets. 
She was also placed in the Trendelenburg 
position. The patient showed poor response 
to adrenaline and phenylephrine infusions. 
Subsequently, she was given hydrocorti-
sone and calcium gluconate. Aortic com-
pression was also applied during this period. 
It was possible to remove the tumour in its 
entirety. The tumour was well circumscribed 
and tan-brown in colour. It measured 11 x 
8.5 x 5 cm and weighed 140 g. Histology 
showed pleomorphic tumour cells arranged 
in well-defined nests (Zell ballen) set in a fi-
brovascular stroma. Immunohistochemical 
stains for synaptophysin and chromogranin 
were positive and the features were con-
sistent with those of a paraganglioma (see 
Figure 3).
Figure 1: Magnetic resonance imaging demonstrating a large pelvic tumour
Figure 2: I-123 metaiodobenzylguanidine (MIBG) scan showing a presacral mass 
with high metaiodobenzylguanidine uptake
Figure 3: Haematoxylin- and eosin-stained section demonstrating Zell ballen set in a vascular stroma, and a chromogranin stain indicating 
strong cytoplasmic positivity
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The patient recovered postoperatively and was 
discharged a few days later with normal blood 
pressure. She required no antihypertensive treatment. 
The postoperative neurological examination was 
normal.
At the six-month follow-up visit, she was normotensive 
and was not on any antihypertensive medication. 
The 24-hour metadrenaline and metnoradrenaline 
levels were normal, and I-123 MIBG and computed 
tomography scans of the abdomen and pelvis showed 
no evidence of recurrence or distant metastases.
Discussion
Paragangliomas and phaeochromocytomas are rare 
causes of hypertension and only 0.1-1% of all cases of 
hypertension are due to these tumours.2 The prevalence 
of paragangliomas and phaeochromocytomas during 
pregnancy is five per million.3 The diagnosis is often 
missed during pregnancy, as the clinical picture mimics 
that of pre-eclampsia, leading to potentially lethal 
complications for both the mother and the foetus.2 
Prior to 1970, maternal mortality was as high as 50%, 
but  it subsequently declined to 2%, mostly because of 
increased antepartum diagnosis.2,4 Foetal mortality has 
declined from 56% to approximately 10%.2,4 
During pregnancy, an undiagnosed paraganglioma 
can lead to a potentially fatal hypertensive crisis 
which can be precipitated by anaesthesia, the 
process of delivery, mechanical effects of the gravid 
uterus, abdominal palpation, uterine contraction and 
foetal movements.2,5 The foetus is protected from the 
direct effects of the high catecholamine levels by an 
enzymatic barrier at the placental level.2 However, 
uteroplacental insufficiency can occur, leading 
to intrauterine growth restriction, miscarriage and 
stillbirth.2,5
The diagnosis of paraganglioma should be considered 
in all pregnant women who present with hypertension 
in early pregnancy, and severe or intermittent 
hypertension, particularly if associated with headaches, 
palpitations, tachycardia and sweating, or episodes of 
sudden collapse.2 
It is more common for extra-adrenal sympathetic para-
gangliomas to be malignant than phaeochromocyto-
mas. Up to 50% give rise to metastases. The incidence 
of malignancy also varies depending on the particu-
lar inherited mutation in the case of familial disease. 
Malignancy is only diagnosed when there is metastasis 
to sites where paraganglial tissue is not usually found.1 
No definite histological criteria predict malignant be-
haviour. Only four features, extra-adrenal location, 
coarse nodularity of the primary tumour, confluent tu-
mour necrosis and absence of hyaline globules, have 
been found to correlate statistically with malignancy.1
A number of syndromes are associated with phae-
ochromocytomas and paragangliomas, including 
multiple endocrine neoplasia types 2A and 2B, von 
Hippel-Lindau syndrome and neurofibromatosis type 1.1 
Familial cases show autosomal-dominant inheritance 
caused by germline mutations in one of 10 susceptibil-
ity genes: RET, VHL, SDHA, SDHB, SDHC, SDHD, SDHAF2, 
NF1, TMEM127 and MAX.6 
Conclusion
We describe a patient who presented with multiple 
foetal losses due to uncontrolled hypertension 
secondary to a noradrenaline-secreting pelvic para-
ganglioma. The paraganglioma, which did not origin-
ate from the organ of Zuckerkandl, was located in a site 
that has rarely been described in the literature before.1
This case demonstrates the importance of a high 
index of suspicion and the rewards of diagnosing a 
resectable, curable cause of hypertension. Ideally, this 
condition should be diagnosed early and managed 
aggressively in order to prevent maternal and foetal 
mortality.
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